723 related articles for article (PubMed ID: 20077416)
1. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
Hsieh TC
Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
[TBL] [Abstract][Full Text] [Related]
4. Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP.
Payton-Stewart F; Schoene NW; Kim YS; Burow ME; Cleveland TE; Boue SM; Wang TT
Mol Carcinog; 2009 Sep; 48(9):862-71. PubMed ID: 19263441
[TBL] [Abstract][Full Text] [Related]
5. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
[TBL] [Abstract][Full Text] [Related]
7. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
[TBL] [Abstract][Full Text] [Related]
8. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
Kai L; Levenson AS
Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
Mitchell SH; Zhu W; Young CY
Cancer Res; 1999 Dec; 59(23):5892-5. PubMed ID: 10606230
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
Hudson TS; Hartle DK; Hursting SD; Nunez NP; Wang TT; Young HA; Arany P; Green JE
Cancer Res; 2007 Sep; 67(17):8396-405. PubMed ID: 17804756
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
Wang TT; Schoene NW; Kim EK; Kim YS
Mol Carcinog; 2013 Sep; 52(9):676-85. PubMed ID: 22495798
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N
Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767
[TBL] [Abstract][Full Text] [Related]
13. Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions.
Chakraborty S; Kumar A; Butt NA; Zhang L; Williams R; Rimando AM; Biswas PK; Levenson AS
Mol Biosyst; 2016 May; 12(5):1702-9. PubMed ID: 27063447
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
Rice L; Handayani R; Cui Y; Medrano T; Samedi V; Baker H; Szabo NJ; Rosser CJ; Goodison S; Shiverick KT
J Nutr; 2007 Apr; 137(4):964-72. PubMed ID: 17374662
[TBL] [Abstract][Full Text] [Related]
16. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
17. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Carcinogenesis; 2007 Jul; 28(7):1533-42. PubMed ID: 17389612
[TBL] [Abstract][Full Text] [Related]
18. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.
Shen JC; Klein RD; Wei Q; Guan Y; Contois JH; Wang TT; Chang S; Hursting SD
Mol Carcinog; 2000 Oct; 29(2):92-102. PubMed ID: 11074606
[TBL] [Abstract][Full Text] [Related]
19. The Resveratrol Tetramer r-Viniferin Induces a Cell Cycle Arrest Followed by Apoptosis in the Prostate Cancer Cell Line LNCaP.
Empl MT; Albers M; Wang S; Steinberg P
Phytother Res; 2015 Oct; 29(10):1640-5. PubMed ID: 26331691
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
Vanamala J; Reddivari L; Radhakrishnan S; Tarver C
BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
